Novel immunological strategies for HIV-1 eradication

B Jülg1, D H Barouch1

  • 1Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

Summary

Despite advances in antiretroviral therapy (ART), HIV-1 persists in cellular reservoirs. This review explores early HIV-1 latency establishment and strategies to disrupt it for viral eradication.